Akihiro Ando Selected Research

TRK 820

1/2022	Clinical Profiles of Nalfurafine Hydrochloride for the Treatment of Pruritus Patients.
10/2016	Drug-Drug Interactions of a Novel κ-Opioid Receptor Agonist, Nalfurafine Hydrochloride, Involving the P-Glycoprotein.
7/2012	Identification of human cytochrome P450 enzymes involved in the metabolism of a novel к-opioid receptor agonist, nalfurafine hydrochloride.
5/2010	[Pharmacological and clinical profiles of nalfurafine hydrochloride (Remitch) capsules 2.5 microg) , a new therapeutic agent for the treatment of uremic pruritus in hemodialysis patients].

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Akihiro Ando Research Topics

Disease

4	Pruritus (Itching) 01/2022 - 05/2010
1	Liver Diseases (Liver Disease) 01/2022
1	Familial Primary Pulmonary Hypertension 02/2017
1	Arterial Occlusive Diseases (Arterial Occlusive Disease) 02/2017
1	Breast Neoplasms (Breast Cancer) 02/2017

Drug/Important Bio-Agent (IBA)

4	TRK 820IBA 01/2022 - 05/2010
2	AntipruriticsIBA 10/2016 - 07/2012
2	Opioid Analgesics (Opioids)IBA 10/2016 - 07/2012
1	Pharmaceutical PreparationsIBA 01/2022
1	Epoprostenol (Prostacyclin)FDA LinkGeneric 02/2017
1	Proteins (Proteins, Gene)FDA Link 02/2017
1	Member 1 Subfamily B ATP Binding Cassette TransporterIBA 02/2017
1	Organic Anion TransportersIBA 02/2017
1	Organic Cation Transporter 1IBA 02/2017
1	beraprostIBA 02/2017
1	Member 11 Subfamily B ATP Binding Cassette TransporterIBA 02/2017
1	Organic Cation Transporter 2IBA 02/2017
1	Multidrug Resistance-Associated Protein 2IBA 02/2017
1	AnionsIBA 02/2017
1	Peptides (Polypeptides)IBA 02/2017

Therapy/Procedure

2	Renal Dialysis (Hemodialysis) 01/2022 - 05/2010
1	Peritoneal Dialysis 01/2022